Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
rated new Buy at Deutsche. $45 price target. Company can deliver double-digit annual earnings growth over the next two years.
downgraded at Janney from Buy to Neutral, Janney Montgomery said. $37 price target. Competition is picking up in the replacement market.
(CA - Get Report)
upgraded at Oppenheimer from Perform to Outperform. Valuation call, based on a $29 price target.
(COP - Get Report)
upgraded at Citi to Hold. Company should benefit from rising oil prices and refining margins.
rated new Buy at UBS. $29 price target. Company has a solid content library.
rated new Neutral at Goldman. $25 price target. Amortization could restrain profitability in the coming quarters.
upgraded at BofA/Merrill from Underperform to Neutral. Valuation call, based on a $31 price target.
upgraded at UBS from Neutral to Buy, UBS said. $30 price target. Estimates also upped, as Chili's is seeing better sales momentum.
upgraded at Stifel from Hold to Buy. $21 price target. Stock is attractive, following a 16% selloff.
rated new Buy at Jefferies. $63 price target. Company is leveraged to an economic recovery.
upgraded at Credit Suisse to Outperform from Neutral on better than expected wireless, transmission, and DTV business, Credit Suisse said. Price target raised to $24 from $17.
rated new Buy at Goldman. $32 price target. Company can expand margins and has room to leverage its balance sheet.
upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $61 price target. Stock is attractive, following an 11% pullback.
upgraded at Barclays to Overweight from Equal Weight as management sees revenue acceleration in 2011, Barclays said. $30 price target.
rated new Buy at UBS. $31 price target. Company can deliver solid growth, but could face increased competition.
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $40 price target. Company can gain significant share in the packaged coffee business.
downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $32.50 price target. Latest survey suggests that the company could be losing market share.